The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Therapeutic modulators of STAT signalling for human diseases
Open accessAbstract
The signal transducer and activator of transcription (STAT) proteins have important roles in biological processes. The abnormal activation of STAT signalling pathways is also implicated in many human diseases, including cancer, autoimmune diseases, rheumatoid arthritis, asthma and diabetes. Over a decade has passed since the first inhibitor of a STAT protein was reported and efforts to discover modulators of STAT signalling as therapeutics continue. This Review discusses the outcomes of the ongoing drug discovery research endeavours against STAT proteins, provides perspectives on new directions for accelerating the discovery of drug candidates, and highlights the noteworthy candidate therapeutics that have progressed to clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–208 of 208
Yang, Y., Jiang, H., Gao, H., Kong, J., Zhang, P., Hu, S., Shi, B., Zhang, P., Yao, M., & Li, Z. (2012) · Neoplasia · doi:10.1593/neo.12328 · Cited by 20
Chen, K., Chen, H., Shiau, C., Liu, C., Chu, P., Tai, W., Ichikawa, K., Chen, P., & Cheng, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02212.x · Cited by 19
Lee, H. K., Seo, I. A., Shin, Y. K., Park, J. W., Suh, D. J., & Park, H. T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.046 · Cited by 19
Zhou, X., Gao, P., & Sun, B. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05067.x · Cited by 19
Nagashima, S., Nagata, H., Iwata, M., Yokota, M., Moritomo, H., Orita, M., Kuromitsu, S., Koakutsu, A., Ohga, K., Takeuchi, M., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.05.031 · Cited by 17
Identification of a novelSTAT3mutation in a patient with hyper-IgE syndrome
Mogensen, T. H., Jakobsen, M. A., & Larsen, C. S. (2012) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2012.715750 · Cited by 13
Muhammad, S., Jiang, Z., Liu, Z., Kaur, K., & Wang, X. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2012.044 · Cited by 13
Zhang, M., Zhu, W., Ding, N., Zhang, W., & Li, Y. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.01.056 · Cited by 9
Cited by
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Karki, R., Sharma, B. R., Tuladhar, S., Williams, E. P., Zalduondo, L., Samir, P., Zheng, M., Sundaram, B., Banoth, B., Malireddi, R. K. S., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.025 · Cited by 1,734
Mechanisms and consequences of Jak–STAT signaling in the immune system
Villarino, A. V., Kanno, Y., & O'Shea, J. J. (2017) · Nature Immunology · doi:10.1038/ni.3691 · Cited by 1,221
Interleukin-6: designing specific therapeutics for a complex cytokine
Garbers, C., Heink, S., Korn, T., & Rose-John, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.45 · Cited by 643
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease
Salas, A., Hernandez-Rocha, C., Duijvestein, M., Faubion, W., McGovern, D., Vermeire, S., Vetrano, S., & Vande Casteele, N. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0273-0 · Cited by 635
Metadata
- Authors
- Miklossy, G., Hilliard, T. S., & Turkson, J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-08
- Volume
- 12
- Issue
- 8
- Pages
- 611-629
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2034038847
- Cited by
- 413
- References
- 208
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.